NOVAVAX INC
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $404.2M | $302.5M | $106.3M |
| FY2018 | $375.9M | $208.0M | $70.2M |
| FY2019 | $359.0M | $173.0M | $78.8M |
| FY2020 | $955.3M | $1.58B | $553.4M |
| FY2021 | $2.93B | $2.58B | $1.52B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $404.2M | $302.5M | $106.3M |
| FY2018 | $375.9M | $208.0M | $70.2M |
| FY2019 | $359.0M | $173.0M | $78.8M |
| FY2020 | $955.3M | $1.58B | $553.4M |
| FY2021 | $2.93B | $2.58B | $1.52B |